Operating
Distributions of earnings from equity method investees
Royalty Pharma Distributions of earnings from equity method investees decreased by 72.2% to $3.72M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 72.2%, from $13.4M to $3.72M. Over 2 years (FY 2021 to FY 2023), Distributions of earnings from equity method investees shows a downward trend with a -26.0% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2018
Last reportedQ1 2026May 6, 2026
Metric ID:
operating_equity_method_investment_dividends_or_distributionsHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.68M | $6.21M | $6.17M | $20.69M | $6.81M | $5.81M | $5.83M | $16.27M | $2.24M | $313K | $0 | $13.4M | $13.4M | $3.72M |
| QoQ Change | — | +32.7% | -0.6% | +235.3% | -67.1% | -14.7% | +0.2% | +179.2% | -86.2% | -86.0% | -100.0% | — | +0.0% | -72.2% |
| YoY Change | — | — | — | — | +45.6% | -6.4% | -5.6% | -21.4% | -67.1% | -94.6% | -100.0% | -17.6% | +0.0% | -72.2% |
Range$0 – $20.69M
CAGR-6.8%
Avg YoY Growth-33.9%
Median YoY Growth-19.5%
Distributions of earnings from equity method investees at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's distributions of earnings from equity method investees?
- Royalty Pharma (RPRX) reported distributions of earnings from equity method investees of $3.72M in Q1 2026.
- How has Royalty Pharma's distributions of earnings from equity method investees changed year-over-year?
- Royalty Pharma's distributions of earnings from equity method investees decreased by 72.2% year-over-year, from $13.4M to $3.72M.
- What is the long-term trend for Royalty Pharma's distributions of earnings from equity method investees?
- Over 2 years (2021 to 2023), Royalty Pharma's distributions of earnings from equity method investees has grown at a -26.0% compound annual growth rate (CAGR), from $34.38M to $18.82M.